Erowid
 
 
Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
References Database

References Search
All References with Titles containing 'nmda' OR with Authors including 'nmda' OR with Abstract including 'nmda' OR with Keywords including 'nmda'


Author Title JournalName Year   D
Click on Column Headers to Re-Sort The Current List
Johnson M, Hanson GR, Gib... Effect of MK-801 on the decrease in tryptophan hydroxylase induced by ... Eur J Pharmacol 1989
Finnegan KT, Skratt JJ, I... The N-methyl-D-aspartate (NMDA) receptor antagonist, dextrorphan, prev... Neurosci Lett 1990
Dragunow M, Logan B, Lave... 3,4-Methylenedioxymethamphetamine induces Fos-like proteins in rat bas... Eur J Pharmacol 1991
Johnson M, Bush LG, Gibb ... Blockade of the 3,4-methylenedioxymethamphetamine-induced changes in n... Eur J Pharmacol 1991
Olney JW, Labruyere J, Wa... NMDA antagonist neurotoxicity: mechanism and prevention Science 1991
Farfel GM, Vosmer GL, Sei... The N-methyl-D-aspartate antagonist MK-801 protects against serotonin ... Brain Res 1992
Krogsgaard-Larsen P, Hans... Naturally-occurring excitatory amino acids as neurotoxins and leads in... Toxicol Lett 1992
Sosnowski M Pain management: physiopathology, future research and endpoints Support Care Cancer 1993
Rossner S, Schliebs R, Bi... Ibotenic acid lesion of nucleus basalis magnocellularis differentially... Brain Res 1994
Farfel GM, Seiden LS Role of hypothermia in the mechanism of protection against serotonergi... J Pharmacol Exp Ther 1995
Sprague JE, Nichols DE The monoamine oxidase-B inhibitor L-deprenyl protects against 3,4-meth... J Pharmacol Exp Ther 1995
Finnegan KT, Taraska T Effects of glutamate antagonists on methamphetamine and 3,4-methylened... J Neurochem 1996
Seiden LS, Sabol KE Methamphetamine and methylenedioxymethamphetamine neurotoxicity: possi... NIDA Res Monogr 1996
Popik P Facilitation of memory retrieval by the 'anti-addictive' alkaloid, ibo... Life Sci 1996
Fitzal S [Ketamine and neuroprotection. Clinical outlook] Anaesthesist 1997
Nikolajsen L, Hansen PO, ... Oral ketamine therapy in the treatment of postamputation stump pain Acta Anaesthesiol Sc... 1997
Nelson KA, Park KM, Robin... High-dose oral dextromethorphan versus placebo in painful diabetic neu... Neurology 1997
Kombian SB, Saleh TM, Fia... Ibogaine and a total alkaloidal extract of Voacanga africana modulate ... Brain Res Bull 1997
Lindefors N, Barati S, O'... Differential effects of single and repeated ketamine administration on... Brain Res 1997
Colado MI, Granados R, O'... Role of hyperthermia in the protective action of clomethiazole against... Br J Pharmacol 1998
Farber NB, Hanslick J, Ki... Serotonergic agents that activate 5HT2A receptors prevent NMDA antagon... Neuropsychopharmacol... 1998
Jones HE, Li H, Balster R... Failure of ibogaine to produce phencyclidine-like discriminative stimu... Pharmacol Biochem Be... 1998
Helsley S, Filipink RA, B... The effects of sigma, PCP, and opiate receptor ligands in rats trained... Pharmacol Biochem Be... 1998
Monks TJ, Ghersi-Egea JF,... Symposium overview: the role of glutathione in neuroprotection and neu... Toxicol Sci 1999
de Bruin NM, Ellenbroek B... Differential effects of ketamine on gating of auditory evoked potentia... Psychopharmacology B... 1999
Kolesnikov YA, Pasternak ... Peripheral blockade of topical morphine tolerance by ketamine Eur J Pharmacol 1999
Arvanov VL, Liang X, Russ... LSD and DOB: interaction with 5-HT2A receptors to inhibit NMDA recepto... Eur J Neurosci 1999
Berman RM, Cappiello A, A... Antidepressant effects of ketamine in depressed patients Biol Psychiatry 2000
West WB, Lou A, Pechersky... Antagonism of a PCP drug discrimination by hallucinogens and related d... Neuropsychopharmacol... 2000
Weinbroum AA, Rudick V, P... The role of dextromethorphan in pain control Can J Anaesth 2000
Russell BR, Laverty R Correlation between 5-HT content and uptake site density following (S)... Ann N Y Acad Sci 2000
Schatz DS, Kaufmann WA, S... 3,4-Methylenedioxymetamphetamine (ecstasy) induces c-fos-like protein ... Synapse 2000
Shirayama Y, Hashimoto K,... 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy)-induced egr-1 mRNA i... Eur J Pharmacol 2000
Mansvelder HD, McGehee DS Long-term potentiation of excitatory inputs to brain reward areas by n... Neuron 2000
Russell BR, Laverty R The effect of (R)-HA966 or ACEA 1021 on dexfenfluramine or (S)-MDMA-in... Pharmacology, Bioche... 2001
Baumann MH, Pablo J, Ali ... Comparative neuropharmacology of ibogaine and its O-desmethyl metaboli... Alkaloids Chem Biol 2001
Vollenweider FX, Geyer MA A systems model of altered consciousness: integrating natural and drug... Brain Res Bull 2001
Krupitsky EM, Burakov AM,... Attenuation of ketamine effects by nimodipine pretreatment in recoveri... Neuropsychopharmacol... 2001
Vollenweider FX Brain mechanisms of hallucinogens and entactogens Dialogues Clin Neuro... 2001
Gouzoulis-Mayfrank E, The... Effects of the hallucinogen psilocybin on covert orienting of visual a... Neuropsychobiology 2002
Gouzoulis-Mayfrank E, The... Effects of the hallucinogen psilocybin on covert orienting of visual a... Neuropsychobiology 2002
Jiang XR, Dryhurst G Inhibition of the alpha-ketoglutarate dehydrogenase and pyruvate dehyd... Chem Res Toxicol 2002
Gandolfi O, Gaggi R, Volt... The activation of serotonin receptors prevents glutamate-induced neuro... Pharmacol Res 2002
Baker AK, Hoffmann VL, Me... Dextromethorphan and ketamine potentiate the antinociceptive effects o... Pharmacol Biochem Be... 2002
Umbricht D, Vollenweider ... Effects of the 5-HT(2A) Agonist Psilocybin on Mismatch Negativity Gene... Neuropsychopharmacol... 2002
Lim DK Ketamine associated psychedelic effects and dependence Singapore Med J 2003
Zalish M, Lavie V Dexanabinol (HU-211) has a beneficial effect on axonal sprouting and s... Vision Res 2003
Passie T, Karst M, Borsut... Effects of different subanaesthetic doses of (S)-ketamine on psychopat... J Psychopharmacol 2003
Darlington CL Dexanabinol: A novel cannabinoid with neuroprotective properties IDrugs 2003
Butelman ER, Harris TJ, K... The plant-derived hallucinogen, salvinorin A, produces kappa-opioid ag... Psychopharmacology (... 2003
Moyano S, Frechilla D, De... NMDA receptor subunit and CaMKII changes in rat hippocampus induced by... Psychopharmacology (... 2004
Kukanich B, Papich MG Plasma profile and pharmacokinetics of dextromethorphan after intraven... J Vet Pharmacol Ther 2004
Chen SL, Huang EY, Chow L... Dextromethorphan differentially affects opioid antinociception in rats Br J Pharmacol 2005
Grasshoff C, Gillessen T,... Ketamine reduces cholinergic modulated GABA release from rat striatal ... Toxicol Lett 2005
Ostroff R, Gonzales M, Sa... Antidepressant Effect of Ketamine During ECT Am J Psychiatry 2005
Lambe EK, Aghajanian GK Hallucinogen-Induced UP States in the Brain Slice of Rat Prefrontal Co... Neuropsychopharmacol... 2005
Narendran R, Frankle WG, ... Altered Prefrontal Dopaminergic Function in Chronic Recreational Ketam... Am J Psychiatry 2005
Tang Y, Zou H, Strong JA,... Paradoxical effects of very low dose MK-801 Eur J Pharmacol 2006
Carliss RD, Radovsky A, C... Oral administration of dextromethorphan does not produce neuronal vacu... Neurotoxicology 2007
Maeng S, Zarate CA, Du J,... Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine:... Biol Psychiatry 2007
Camarasa J, Marimon JM, R... Memantine prevents the cognitive impairment induced by 3,4-methylenedi... Eur J Pharmacol 2008
Dinis-Oliveira RJ, Carval... Suicide by hanging under the influence of ketamine and ethanol Forensic Sci Int 2010
Reissig CJ, Carter LP, Jo... High doses of dextromethorphan, an NMDA antagonist, produce effects si... Psychopharmacology (... 2012
Sanacora G, Smith MA, Pat... Lanicemine: a low-trapping NMDA channel blocker produces sustained ant... Mol Psychiatry 2013
de Sousa Fernandes Perna ... Memory and mood during MDMA intoxication, with and without memantine p... Neuropharmacology 2014
Nagele P, Duma A, Kopec M... Nitrous Oxide for Treatment-Resistant Major Depression: a Proof-of-Con... Biological Psychiatr... 2014
Van Hout MC, Hearne E Word of mouse: indigenous harm reduction and online consumerism of the... J Psychoactive Drugs 2015
McLaughlin G, Morris N, K... Test purchase, synthesis, and characterization of 2-methoxydiphenidine... Drug Test Anal 2015
Bäckberg M, Beck O, Helan... Phencyclidine analog use in Sweden--intoxication cases involving 3-MeO... Clin Toxicol (Phila) 2015
Zorumski CF, Nagele P, Me... Treatment-Resistant Major Depression: Rationale for NMDA Receptors as ... Front Psychiatry 2015
Litjens RP, Brunt TM How toxic is ibogaine? Clin Toxicol (Phila) 2016
Das RK, Tamman A, Nikolov... Nitrous oxide speeds the reduction of distressing intrusive memories i... Psychol Med 2016
Wallach J, Kang H, Colest... Pharmacological Investigations of the Dissociative 'Legal Highs' Diphe... PLoS One 2016
Kang H, Park P, Bortolott... Ephenidine: A new psychoactive agent with ketamine-like NMDA receptor ... Neuropharmacology 2017
Heal DJ, Gosden J, Smith ... Evaluating the abuse potential of psychedelic drugs as part of the saf... Neuropharmacology 2018
Ingram R, Kang H, Lightma... Some distorted thoughts about ketamine as a psychedelic and a novel hy... Neuropharmacology 2018
Bertron JL, Seto M, Linds... DARK Classics in Chemical Neuroscience: Phencyclidine (PCP) ACS Chem Neurosci 2018
Botanas CJ, de la Peña JB... Methoxetamine: A foe or friend? Neurochem Int 2019
Martial C, Cassol H, Char... Neurochemical models of near-death experiences: a large-scale study ba... Conscious Cogn 2019